(KUN)

China Shenghuo Pharma

Close Price:
0.14

Change:
-0.04 Stock Price Decrease0.04

% Change:
-0.2222222222222222222222222222 Stock Price Decrease22.22 %

Date:
5/8/2012

52 Week:
0.06 - 0.89

Prev Close:
0.18

Open:
0.14

Volume:
12,000

90D Avg. Volume:
24,831

5/8/2012 Range:
0.14 - 0.14

Market Cap:
2,755,200

Trailing PE Ratio:
14.00

Shares Out:
19,680,000

EPS:
0.01

Yield:
0.00

Dividend:
0.00

Dividend Date:
-

Quarter End:
6/30/2013

China Shenghuo Pharma

Website: www.shenghuo.com.cn

Business Summary: Founded in 1995, China Shenghuo is a specialty pharmaceutical company that focuses on the research, development, manufacture and marketing of Sanchi-based medicinal and pharmaceutical, nutritional supplement and cosmetic products. Through its subsidiary, Kunming Shenghuo Pharmaceutical (Group) Co., Ltd., it owns thirty SFDA (State Food and Drug Administration) approved medicines, including the flagship product Xuesaitong Soft Capsules, which has already been listed in the Insurance Catalogue. At present, China Shenghuo incorporates a sales network of agencies and representatives throughout China, which markets Sanchi-based traditional Chinese medicine to hospitals and drug stores as prescription and OTC drugs primarily for the treatment of cardiovascular, cerebrovascular and peptic ulcer disease. The Company also exports medicinal products to Asian countries such as Indonesia, Singapore, Japan, Malaysia, and Thailand and to European countries such as the United Kingdom, Tajikstan, Russia and Kyrgyzstan.



,

KUN Earnings Calendar

Q1:
Dec
31
 -
Mar
30
Q2:
Mar
31
 -
Jun
30
Q3:
Jun
30
 -
Sep
29
Q4:
Sep
30
 -
Dec
30
Period Ending
 
Assets
Current Assets
Cash & Cash Equivalents
Short Term Investments
Net Receivables
Inventory
Other Current Assets
Total Current Assets
Long Term Assets
Property Plant & Equipment
Goodwill
Intangible Assets
Accumulated Amortization
Other Assets
Deferred Long Asset Charges
Total Assets
Liabilities
Current Liabilities
Accounts Payable
Short/Current Long Term Debt
Other Current Liabilities
Total Current Liabilities
Long Term Debt
Other Liabilities
Deferred Long Term Liability Charges
Minority Interest
Negative Goodwill
Total Liabilities
Stockholders' Equity
Misc Stock Options Warrants
Redeemable Preferred Stock
Preferred Stock
Common Stock
Retained Earnings
Treasury Stock
Capital Surplus
Other Stockholder Equity
Total Stockholder Equity
Net Tangible Assets
12/31/2009
 
 
 
$1,987
$0
$20,066
$3,896
$0
$26,360
$0
$12,066
$0
$1,127
$0
$0
$370
$39,923
 
 
$16,855
$9,405
$7,037
$33,297
$5,850
$0
$0
$1
$0
$39,149
 
$0
$0
$0
$2
$0
$0
$6,194
$1,736
$775
($353)
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
YoY
 
 
 
23.3%
0.0%
10.3%
(9.1%)
0.0%
9.2%
(100.0%)
59.1%
0.0%
69.2%
0.0%
0.0%
0.0%
20.8%
 
 
199.8%
(28.2%)
26.8%
37.2%
417.2%
0.0%
0.0%
(99.6%)
0.0%
52.6%
 
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
(3.8%)
(89.5%)
(105.2%)
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
12/31/2008
 
 
 
$1,612
$0
$18,193
$4,287
$0
$24,133
$663
$7,582
$0
$666
$0
$0
$0
$33,044
 
 
$5,622
$13,096
$5,551
$24,269
$1,131
$0
$0
$248
$0
$25,648
 
$0
$0
$0
$2
$0
$0
$6,194
$1,804
$7,396
$6,730
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
YoY
 
 
 
(42.4%)
0.0%
(6.8%)
3.9%
0.0%
(9.3%)
29.0%
0.1%
0.0%
2.8%
0.0%
0.0%
0.0%
(6.5%)
 
 
46.7%
38.8%
61.4%
45.3%
(83.5%)
0.0%
0.0%
(48.2%)
0.0%
6.8%
 
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
67.5%
(34.6%)
(36.9%)
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
Period Ending
 
Assets
Current Assets
Cash & Cash Equivalents
Short Term Investments
Net Receivables
Inventory
Other Current Assets
Total Current Assets
Long Term Assets
Property Plant & Equipment
Goodwill
Intangible Assets
Accumulated Amortization
Other Assets
Deferred Long Asset Charges
Total Assets
Liabilities
Current Liabilities
Accounts Payable
Short/Current Long Term Debt
Other Current Liabilities
Total Current Liabilities
Long Term Debt
Other Liabilities
Deferred Long Term Liability Charges
Minority Interest
Negative Goodwill
Total Liabilities
Stockholders' Equity
Misc Stock Options Warrants
Redeemable Preferred Stock
Preferred Stock
Common Stock
Retained Earnings
Treasury Stock
Capital Surplus
Other Stockholder Equity
Total Stockholder Equity
Net Tangible Assets
6/30/2010
 
 
 
$1,338
$0
$21,070
$3,724
$0
$26,933
$0
$13,172
$0
$0
$0
$1,611
$0
$41,716
 
 
$21,755
$5,842
$0
$29,663
$11,398
$0
$0
($94)
$0
$40,966
 
$0
$0
$0
$2
$0
$0
$6,194
$1,740
$750
$750
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
QoQ
 
 
 
86.6%
0.0%
19.9%
10.8%
0.0%
24.2%
(100.0%)
74.8%
0.0%
(100.0%)
0.0%
0.0%
0.0%
33.3%
 
 
72.8%
(54.3%)
(100.0%)
(3.2%)
0.0%
0.0%
0.0%
0.0%
0.0%
33.7%
 
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
(3.7%)
13.3%
628.2%
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
3/31/2010
 
 
 
$864
$0
$20,820
$3,350
$0
$25,634
$0
$12,877
$0
$0
$0
$1,544
$0
$40,055
 
 
$21,519
$9,334
$0
$33,427
$5,851
$1,018
$0
($1)
$0
$39,277
 
$0
$0
$0
$2
$0
$0
$6,194
$1,737
$778
$778
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
QoQ
 
 
 
(5.0%)
0.0%
12.8%
(11.5%)
0.0%
10.6%
(100.0%)
73.1%
0.0%
(100.0%)
0.0%
0.0%
0.0%
23.2%
 
 
0.6%
0.0%
(100.0%)
25.6%
300.5%
0.0%
0.0%
0.0%
0.0%
39.9%
 
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
(3.7%)
(82.5%)
(79.6%)
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
Period Ending
Net Income
Operating Activities
Depreciation
Adjustments To Net Income
Changes In Accounts Receivables
Changes In Liabilities
Changes In Inventories
Changes In Other Operating Activities
Total from Operating Activities
Investing Activities
Capital Expenditures
Investments
Other Investing Activities
Total from Investing Activities
Financing Activities
Dividends Paid
Sale Purchase of Stock
Net Borrowings
Other Financing Activites
Total from Financing Activities
Effect of Exchange Rate Changes
Change in Cash and Cash Equivalents
12/31/2009
($6,554)
 
$777
$617
($2,779)
$8,760
$424
$1,497
$2,499
 
($3,121)
$0
$0
($3,121)
 
$0
$0
$992
$0
$992
$4
$374
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
YoY
(41.2%)
 
(5.5%)
(71.1%)
(3,709.1%)
163.7%
275.2%
1,147.5%
28.4%
 
(926.6%)
0.0%
0.0%
(926.6%)
 
0.0%
0.0%
133.0%
0.0%
133.0%
(97.8%)
131.5%
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
12/31/2008
($4,643)
 
$822
$2,136
$77
$3,322
$113
$120
$1,947
 
($304)
$0
$0
($304)
 
$0
$0
($3,009)
$0
($3,009)
$178
($1,189)
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
YoY
(369.9%)
 
21.4%
220.7%
101.3%
481.8%
108.6%
185.1%
138.7%
 
(72.7%)
(100.0%)
(100.0%)
(180.4%)
 
0.0%
(100.0%)
(235.7%)
0.0%
(184.5%)
(13.6%)
(33.4%)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Period Ending
Net Income
Operating Activities
Depreciation
Adjustments To Net Income
Changes In Accounts Receivables
Changes In Liabilities
Changes In Inventories
Changes In Other Operating Activities
Total from Operating Activities
Investing Activities
Capital Expenditures
Investments
Other Investing Activities
Total from Investing Activities
Financing Activities
Dividends Paid
Sale Purchase of Stock
Net Borrowings
Other Financing Activites
Total from Financing Activities
Effect of Exchange Rate Changes
Change in Cash and Cash Equivalents
6/30/2010
($31)
 
$0
$0
$0
$0
$0
$0
($561)
 
($4,197)
$0
$3,286
($911)
 
$0
$0
$1,944
$0
$1,944
$2
$474
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
QoQ
99.2%
 
(100.0%)
0.0%
(100.0%)
(100.0%)
(100.0%)
100.0%
(716.5%)
 
(1,404.3%)
0.0%
0.0%
(226.5%)
 
0.0%
0.0%
1,867.3%
0.0%
48,700.0%
0.0%
348.2%
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
3/31/2010
$2
 
$0
$0
$0
$0
$0
$0
$2,022
 
$0
$0
($3,073)
($3,073)
 
$0
$0
($72)
$0
($72)
$0
($1,123)
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
QoQ
100.1%
 
(100.0%)
100.0%
100.0%
(100.0%)
(100.0%)
(100.0%)
127.2%
 
100.0%
0.0%
0.0%
(10,496.6%)
 
0.0%
0.0%
95.4%
0.0%
95.4%
(100.0%)
(59.7%)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Period Ending
Total Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Research Development
Selling General & Administrative
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss
Income from Continuing Operations
Total Other Income/Expenses Net
Earnings Before Interest And Taxes
Interest Expense
Income Before Tax
Income Tax Expense
Minority Interest
Net Income From Continuing Ops
 
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares
12/31/2009
$36,002
$9,888
$26,114
 
$140
$33,202
$0
$0
$0
($7,228)
 
($34)
($6,918)
$934
($7,851)
($1,054)
$244
($6,210)
 
 
$0
$0
$0
$0
($6,554)
$0
($6,554)
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
YoY
25.5%
28.5%
24.4%
 
(58.7%)
37.6%
0.0%
0.0%
0.0%
(108.1%)
 
(109.9%)
(121.0%)
(28.7%)
(76.8%)
(340.6%)
3.8%
(33.7%)
 
 
0.0%
0.0%
0.0%
0.0%
(41.2%)
0.0%
(41.2%)
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
12/31/2008
$28,691
$7,694
$20,997
 
$339
$24,131
$0
$0
$0
($3,473)
 
$343
($3,130)
$1,310
($4,440)
$438
$235
($4,643)
 
 
$0
$0
$0
$0
($4,643)
$0
($4,643)
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
YoY
43.6%
52.7%
40.6%
 
24.6%
89.7%
0.0%
0.0%
0.0%
(278.6%)
 
(12.7%)
(233.9%)
38.5%
(419.2%)
197.6%
297.5%
(369.9%)
 
 
0.0%
0.0%
0.0%
0.0%
(369.9%)
0.0%
(369.9%)
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
Period Ending
Total Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Research Development
Selling General & Administrative
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss
Income from Continuing Operations
Total Other Income/Expenses Net
Earnings Before Interest And Taxes
Interest Expense
Income Before Tax
Income Tax Expense
Minority Interest
Net Income From Continuing Ops
 
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares
9/30/2010
$8,551
$2,997
$5,555
 
$161
$4,744
$0
$0
$0
$650
 
$428
$1,078
$129
$949
$118
($43)
$788
 
 
$0
$0
$0
$0
$788
$0
$788
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
QoQ
(19.0%)
1.7%
(27.0%)
 
1,363.6%
(41.1%)
0.0%
0.0%
0.0%
243.8%
 
1,326.7%
356.1%
(22.3%)
261.4%
129.4%
(127.7%)
2,562.5%
 
 
0.0%
0.0%
0.0%
0.0%
2,562.5%
0.0%
2,562.5%
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
6/30/2010
$6,882
$2,489
$4,393
 
$176
$3,883
$0
$0
$0
$335
 
$8
$539
$524
$15
$53
$7
($31)
 
 
$0
$0
$0
$0
($31)
$0
($31)
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
QoQ
(15.4%)
3.9%
(23.4%)
 
2,414.3%
(58.4%)
0.0%
0.0%
0.0%
109.3%
 
(92.2%)
116.6%
95.5%
100.4%
0.0%
0.0%
99.2%
 
 
0.0%
0.0%
0.0%
0.0%
99.2%
0.0%
99.2%